NRSN

NeuroSense Therapeutics Ltd.

HealthcareBiotechnologyILUSDPeers →Country macro →

$0.80

LiveJun 18, 2026

Market cap

$19.85M

52w range

0.63 – 2.35

P / E

—

EPS

—

Volume

241.04K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on NeuroSense Therapeutics Ltd.’s valuation

○

Sell-side estimates and price targets skew heavily to US large-caps. We don't have consensus data for this issuer yet.